Condition
Pleural Metastases
Total Trials
5
Recruiting
2
Active
2
Completed
2
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 5 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 2 completed with results
Key Signals
100% success
Data Visualizations
Phase Distribution
4Total
P 1 (2)
P 2 (2)
Trial Status
Completed2
Recruiting2
Unknown1
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 2 completed trials
Clinical Trials (5)
Showing 5 of 5 trials
NCT05354570Phase 2Recruiting
A Study of Intensity-Modulated Pleural Radiation Therapy (IMPRINT) in People With Thymic Cancer That Has Spread to the Lining of the Lungs and Chest
NCT04200417Phase 1Completed
Chemoembolization for Lung Tumors
NCT06726564Phase 1Recruiting
A Study of MT027 in Patients with Pleural Malignant Tumors
NCT05910112Unknown
Prospective Data Collection on Clinical, Radiological and Patient Reported Outcomes After Pleural Intervention
NCT01163552Phase 2CompletedPrimary
Heated Chemotherapy for Cancers That Have Spread to the Chest Cavity
Showing all 5 trials